Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel ...
UCB, a global biopharmaceutical company, today announced three-year data from the BE HEARD trials for BIMZELX® (bimekizumab-bkzx) in moderate-to-severe hidradenitis suppurativa (HS). BIMZELX, the ...
Need a last minute costume idea? Canadian nail artists share their tricks for getting spooky-chic Halloween nails.
Investor's Business Daily on MSN
Coal Stocks Pare Gains Amid The Rare Earths Craze
Stocks for some coal companies are up 200% this year, as investors hope they'll reinvent themselves as rare earth miners.
Objective In China, a large number of health-related short videos are posted on video platforms, including educational videos ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback